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Kurzbericht I Brief report 
I Development of a monitoring system 
for heroin-assisted substitution treatment 
in Switzerland 
Summary  
Objectives: Switzerland introduced heroin-assisted treatment 
as a routine treatment for drug addicts. As a result the evalua- 
tion instruments were changed from a detailed scientific pro- 
ject to a routine monitoring system. The process for developing 
this monitoring system is described. 
Methods:  The questionnaires and assessment instruments 
were restyled with staff of the treatment agencies. Indicators 
measuring quality of treatment and measures from the future 
national statistic on the addiction support system were inte- 
grated into admission, course and discharge questionnaires. 
Currently a system for feedback to treatment agencies is being 
developed. 
Results: All 21 treatment agencies are participating in the 
monitoring. Assessment quality is high. 
Conclusions: The described monitoring should provide con- 
tinuous delivery of basic relevant data on patients. 
Keywords: Heroin prescription - Monitoring - Switzerland - Opioid 
addiction - Treatment. 
Opiate addiction constitutes a major public health problem 
in Switzerland (Bundesamt ffir Gesundheit 1998; Gruel 
1997; Gmel & Maag 1999; Rehm 1995a; Rehm 1995b; 
Schweiz. Fachstelle for Alkohl- und andere Drogenprob- 
leme 1999). To reduce the consequences of opiate addiction 
an integrated strategy including prevention, abstinence 
treatment, harm reduction, and repression measures has 
been developed and evaluated (Gervasoni et al. 2000). 
One part of this strategy was the Swiss Medical Prescription 
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of Narcotics Research Program (PROVE). Within this 
programme, it is possible to prescribe heroin, morphine and 
methadone for treatment purposes to opiate addicts for 
whom other treatment was ineffective. 
Based on the positive outcomes of a first experimental 
phase of this programme (Uchtenhagen etal. 1999), heroin- 
assisted treatment has been implemented in Switzerland as 
part of an integrated overall treatment system for a specific 
target population (Tab. 1). Following the completion of the 
research phases it became a routine therapy programme. 
Currently, there are around 1200 treatment slots for this 
form of treatment available in Switzerland. 
As the treatment shifted from experimental toroutine treat- 
ment, the form of evaluation had to change as well. Follow- 
ing a general trend in public health, a monitoring system 
was established (Teutsch & Churchill 2000). Monitoring 
systems allow focussed and continuously updated surveil- 
lance of health in the general population. They have been 
established also in the area of illicit drugs. Such monitoring 
systems comprise mainly epidemiological developments, 
which can be used to predict health services needs (e.g., the 
European Monitoring Centre for Drugs and Drug Addic- 
tion (EMCDDA), see www.emcdda.org). However, mo- 
nitoring does not have to be restricted to epidcmiology. 
Treatment monitoring systems can provide important infor- 
mation about trends in treatment needs and health services 
utilisation patterns, e.g., the German EBIS and SEDOS 
now called EBIS-A and EBIS-S (T0rk & Welsch 2000a; 
Ttirk & Welsch 2000b); or integrated information for spe- 
cialised addiction treatment agencies (Ogborne t al. 1998). 
This article describes the development of a system to moni- 
tor heroin-assisted treatment in Switzerland systematically 
by establishing electronically registered intake, follow-up 
and discharge interviews. One aim of this system is to make 
available diagnostic and anamnestic information on the 
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health and social situation of patients at entry, during the 
course of treatment and at discharge (Tab. 2). 
Research on heroin-assisted treatment in Switzerland 
Study PROVE 1994 to 1997 
In the study on medical prescription of opiates (PROVE), 
800 treatment slots had been set up for heroin substitution i
Switzerland between 1994 and 1996 (Uchtenhagen et al 
1996a; Uchtenhagen etal. 1996b; Uchtenhagen etal. 1997). 
Between 1.1.1994 and 30.6.1996, 1035 clients entered the 
programme. The first phase of research ended by December 
31 st, 1996. 
The analyses howed - according to the entry criteria - that 
a group of long-time opiate addicts with severe social and 
health problems could be reached (Uchtenhagen et al. 
1999). A sub-sample of 237 patients, who had been in treat- 
ment for at least 18 months, showed marked improvement 
of their social and health status (Steffen et al. 1999). The 
results of this research have led to a wider international 
discussion of heroin-assisted treatment (Drucker & Vlahov 
1999; Farrell & Hall 1998; Krausz & Behrendt 1998; Soyka 
1998; World Health Organization 1999). 
Second phase of research 1998 to 1999 
At the end of the first phase of research on June 30, 1996, 
due to legal reasons no new clients could enter into heroin- 
assisted treatment in Switzerland. Only after the 1997 re- 
vision of the Swiss government decree on fostering scientific 
evaluation on methods for drug prevention and improve- 
ment of living conditions of drug addicts, could new clients 
be recruited. 
In the first phase of research of the heroin-assisted treat- 
ment, basically the feasibility of this new treatment form 
and its overall outcome had been analysed, while research 
in 1998 and 1999 focused mainly on medical and social 
ancillary care in heroin-assisted treatment programmes 
(Steffen et al. 1999). 
Third phase of research since 2000 
At present, heroin-assisted treatment in Switzerland isbeing 
transferred from a research programme into a routine treat- 
ment programme. However, heroin-assisted treatment will 
only be conducted inappropriate and interdisciplinary treat- 
ment centres. The indication criteria will remain the same, 
with the exception of minimum age, which was lowered from 
20 to 18 (Tab. 1). This guarantees that heroin-assisted treat- 
ment can be integrated into the existing therapeutic network 
as an additional treatment for long-term heroin addicts. 
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Table 1. Entry criteria for heroin-assisted treatment 
As a result of the new phase, the old evaluation instruments 
had to be revised. To establish the basis for future studies 
and to provide current data on heroin-assisted treatment, a 
monitoring system has been installed. In the following 
chapters we outline the process of establishing this monitor- 
ing system. 
Monitoring system HeGeBe 
Aims 
The purpose of the monitoring system is to: 
1. Provide standardised information on characteristics 
of patients entering heroin-assisted treatment, on the 
course and outcome of heroin-assisted treatment, and on 
problems and complications with such treatment. 
As of 2001, the monitoring system will provide quickly and 
easily standardised ata on heroin-assisted treatment in 
Switzerland. Furthermore, the full monitoring system will al- 
low representative statements of the client's development 
and of this new therapeutic programme. Particularly self re- 
ports on key issues will be confirmed, e.g., current valida- 
tion of cocaine, benzodiazepine, and amphetamine side 
consumption. Questions on patient's illegal activities have 
already been validated by objective judicial data in an inde- 
pendent investigation (Kilias & Rabasa 1998). 
2. Provide timely feedback to treatment institutions with 
respect to monitoring treatment. 
Relevant follow-up information will be available within one 
month after evaluation i  order to allow for possible changes 
in the therapeutic programme. This is not feasible at present. 
Currently checking of data (plausibility controls, checks 
for completeness, etc.) and reporting usually takes several 
months thereby often rendering data irrelevant as new 
developments constantly occur. At present, a better data 
concept is being developed, which will allow us to provide 
timely feedback not only to the treating institutions but also 
to the Swiss Federal Office for Public Health (BAG) (Fig. 1). 
An information system will be established, which will 
automatically integrate new information obtained from 
intake and discharge interviews. It would also integrate 
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Figure 1. The role of an information system 
automatically the follow-up information (e.g., evaluation 
with notebook and CAPI systems) and also report half- 
automated deviation from the estimated figure. 
3. Generate knowledge on how to best implement heroin- 
assisted treatment and a system for monitoring treat- 
ment programmes for dependent people. 
With the evaluation and combination of various data (pos- 
sibly also from other studies), different questions can be 
formulated. To accomplish this aim, a new open database 
will be established which will integrate all data from the 
three phases on heroin-assisted treatment in Switzerland. 
Thus, indications for appropriate treatment of individual 
client groups can be obtained. This information will be given 
to other counselling agencies in the drug field, especially 
to projects which are involved with methadone-assisted 
treatment. 
Moreover, monitoring HeGeBe serves as a pilot study for 
the implementation f a national statistic on addiction treat- 
ment. In a project, which is known under the name of "act- 
info" (http://www.act-info.ch), data from hospitals and coun- 
selling agencies will be transferred into a national statistic, 
which is standardised and widely compatible. It will also 
contain evaluations of an information etwork, which will be 
available to all participating treatment centres (Bundesamt 
fiJr Gesundheit & Bundesamt fiir Statistik 2000). 
4. Contribute to the quality management system for hero- 
in-assisted treatment in Switzerland. 
Currently, various activities are underway to establish the 
quality management system HeGeBe. The supply of reliable 
and compatible data on the treatment offer and course of 
treatment will ensure that not only the quality of heroin-as- 
sisted treatment will be gained but also further develop- 
ments will be possible (Bundesamt far Gesundheit 2000). 
Different relevant indicators for quality management are 
evaluated by the monitoring system HeGeBe. Since the 
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monitoring system will provide data as a basis for research 
and decision-making, it will also contribute considerably 
to the improvement and further development of heroin- 
assisted treatment. 
5. Provide a basis for in-depth research. 
The described monitoring system provides the essential ba- 
sis for future studies which will combine additional data with 
the basic variables. Therefore, data can be analysed within a 
wider framework. 
Principles and content 
The monitoring system HeGeBe provides information on 
clients who are in treatment. The aim is the evaluation and 
documentation of heroin-assisted treatment in a slender 
basic statistic. The new instruments of monitoring allow us 
also to evaluate various indicators for quality management. 
It is therefore an important instrument for quality manage- 
ment. Furthermore, the monitoring system HeGeBe will be 
part of "act-info" (s. a.) as a pilot. All key variables of the 
"act-info" system will also be included in the HeGeBe 
monitor. 
As of 2001, relevant psychosocial nd medical data will be 
evaluated in the monitoring system. It is planned to establish 
intake, yearly course of treatment and discharge interviews 
(Tab. 2). 
Implementation 
As a first step, the current questionnaires u ed for the eval- 
uation of heroin-assisted treatment were re-examined. The 
participating treatment centres had the opportunity to 
provide feedback for the planned monitoring system in 
2001. 
A working group with representatives from the treatment 
centres, the BAG and the Addiction Research Institute 
(ISF) undertook the re-examination. Key areas of the 
monitoring concern the patient's ocial and medical situa- 
tion as well as substance consumption at entry and during 
the course of treatment. While the research load had to 
be shortened, the data should be compatible with data 
from prior research. Thus, the new questionnaire was de- 
signed in a way to allow comparisons of key variables and 
to be consistent with standard instruments like EuropASI 
or the SCL-90-R rating scales (symptom-check-list-90- 
revised). In addition, key variables from the new national 
monitoring system "act-info" were integrated as well as 
indicators from the commission on quality control and 
development in heroin-assisted treatment. The end product 
also had to be substantially shorter than the prior instru- 
ments. 
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Table 2, Overview of data, which have to be collected 
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Treatment centres and the BAG were then given one 
month to comment on the new questionnaires. Feedback 
was mainly positive. The suggested changes were discussed 
in the above-mentioned working group and a revised 
version was developed. In November and December 2000, 
the revised questionnaires were piloted in all treatment 
centres. Then, the questionnaires were revised slightly 
again. The implementation of the final questionnaires 
started in 2001. 
Discussion 
A project like a monitoring system depends on the motiva- 
tion and involvement of staff in the participating treatment 
centres who are in charge of data collection. Therefore, 
treatment staff has been encouraged to participate in the 
work and share the responsibility. All treatment centres 
have been systematically involved during the process of 
developing and establishing the monitoring system. Question- 
naires as well as the CAPI (Computer-Assisted Personal 
Interview) have been discussed in working groups involving 
members from treatment centres. Furthermore, special 
emphasis was placed on comprehensive information for all 
treatment providers in all phases of the project. The response 
and specific needs of the treatment centres were then taken 
into consideration. With this procedure, we hope to counter- 
act potential fears often associated with the implementation 
of new statistics, e.g., that such statistics could seem to allow 
comparisons between performance of treatment institutions 
and eventually would lead to reduced funding for some 
institutions (Ogborne t al. 1998). First experiences are posi- 
tive but the full implementation is still ahead. 
Conclusions 
We hope that this monitoring system will provide the basic 
data needed for long-term evaluation of heroin-assisted 
treatment. With regard to the national and international 
attention which the project on heroin-assisted treatment has 
received, data collection and ongoing research are necessary 
so that examination of this new treatment programme is 
ensured. 
The monitoring system is conceived to be permanent. It 
serves as a pilot for other monitoring systems and the evolv- 
ing national statistic on substance abuse treatment. 
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von Patienten der heroingestQtzten Behandlung langfristig 
gew~hrleisten. 
R~sum~ 
Zusammenfassung 
Entwicklung eines Monitoringsystems fiJr die heroingestCitzte 
Behandlung in der Schweiz 
Fragestellung: Mit der 0berf0hrung der heroingest0tzten Be- 
handlung von Drogenabh~ngigen i  der Schweiz vom Studien- 
betrieb in eine Routinebehandlung wurden die Instrumente 
der Begleitforschung angepasst und ein Monitoringsystem ein- 
gerichtet. Die Aufgaben dieses Monitoring und seine Imple- 
mentierung werden beschrieben. 
Methoden" Zusammen mit Vertretern der Behandlungsstellen 
wurden die bisher verwendeten Fragebogen im Jahr 2000 
Qberarbeitet. Indikatoren zur Messung der Qualit~tsentwick- 
lung und Variablen der k0nftigen nationalen Suchthilfestatis- 
tik wurden in die neuen Eintritts-, Verlaufs- und Austrittsfrage- 
bogen integriert. Ein System for den Datenr0ckfluss an die Be- 
handlungsstellen wird entwickelt. 
Ergebnisse: Zur Zeit nehmen alle 21 Behandlungsstellen am 
Monitoring teil. Die Datenerhebung in den Behandlungsstel- 
len I~uft gut. 
Schlussfolgerungen: Das hier beschriebene Monitoringsystem 
wird die fortlaufende Erhebung der essentiellen Basisdaten 
D~veloppement d'un syst~me de surveillance pour le 
traitement de maintenance & I'h~roi'ne en Suisse 
Objectifs: Avec le passage de la prescription mEdicale d'h&ofne 
aux personnes dependantes des opiacEs en Suisse du stade 
d'etude ~ celui de traitement de routine, les instruments de 
recherche ont ~t~ adapt~s et un systEme de monitoring a EtE 
mis sur pied. La nature des t~ches remplies par le monitoring 
est d~crite, ainsi que la mani&e dont ce dernier a ~t~ mis en 
place. 
M~thodes: Les anciens questionnaires ont ~t~ modifies au 
cours de I'ann~e 2000, en collaboration avec les repr~sentants 
des centres de traitement. Les indicateurs mesurant I'~volution 
de la qualit~ et les variables de la future statistique nationale 
d'aide aux personnes dependantes ont et~ int~gres dans 
les nouveaux questionnaires d'entr~e, d'~volution et de sortie. 
Un syst~me de retour des donn~es aux centres de traitement 
doit encore ~tre d~velopp& 
Resultats: Les 21 centres de traitement de maintenance 
I'h&o'fne participent actuellement au projet. La r~colte des 
donn~es dans les centres de traitement fonctionne bien. 
Conclusions: Avec le syst~me de monitoring d~crit, la r~colte 
des donn~es de base des patients en traitement de main- 
tenance ~ I'herofne peut &tre garantie ~ long terme. 
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